Kliniske forsøg sponsoreret af Kyowa Hakko Kogyo (Japan) providing the amino acids
I alt 1 resultater
-
Assistance Publique - Hôpitaux de ParisKyowa Hakko Kogyo (Japan) providing the amino acidsAfsluttetÆldre | MetabolismeFrankrig
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Caritas Freetown
- San MediTech(Huzhou)Co.,Ltd.
- Donders Institute for Brain, Cognition and Behavior
- AMTC & Associates
- Rui-hua Xu, MD, PhD
- Cardresearch
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Diego Hernan Giunta, MD
- ProteoSys AG
- Norsk Proteinintolerance, Norway
- Victor Montori
- Societa Italiana di Endoscopia Digestiva
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- CRMBM-CEMEREM
- The Fifth Affiliated Hospital of Zunyi Medical College
- Alberta Children's Hospital, Calgary, Canada
- Elim Pediatric Pharmaceuticals Inc.
- Fondren Orthopedic Group L.L.P.
- Celtaxsys Aus Pty Limited
- University Medical Center Goettingen
- Se den fulde liste
Medicinske tilstande
- Lymfødem af Arm
- Ondartet ascites på grund af epitelkarcinom
- Orbital tumor
- Tulariæmi
- Feber, svedeture og hedeture
- Normal diameter af synsnerven
- Spermatogenese arrestation
- Postkomatøs ubevidsthedstilstand
- Atrieflimren, postoperativ
- Gynækologisk kræft
- Stereotaktisk radioablation for ventrikulær takykardi
- Ikke-dystrofiske myotonier
- Rørlidelser Eustachian
- Prostatakræft Tilbagevendende
- Plasmodium Falciparum Malaria (resistent mod medicin)
- Fibromyalgi syndrom, primært
- Analgetika, antipyretika og antirheumatics, der forårsager uønskede virkninger i terapeutisk brug
- Forstyrrelse af aktivitet og opmærksomhed
- Auditiv Hallucination, Verbal
- Ikke-komprimerbar torsoblødning
- Se den fulde liste
Narkotikainterventioner
- Oxycodon, fentanyl
- Ruxolitinib
- Flibanserin 100 mg dosis hver aften
- PF-00868554
- Cetrorelix 78 mg + 78 mg
- Mupirocin Calcium
- HB-202 / HB-201 alternerende intravenøs administration + standardbehandlingsregime inklusive pembrolizumab.
- Polyethylenglycol 3350
- Enzalutamid, Abirateron
- Methotrexat
- Atezolizumab
- Epimedium-prenylflavonoidekstrakt
- CTx-1301-Dexmethylphenidat 18,75 mg (randomiseret fast dosis)
- Cytarabin ARA-C
- Topotecan
- Lamivudin
- Insulin
- Bortezomib/dexamethason
- SERETIDE Diskus
- Indoximod
- Se den fulde liste
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Gambia
- Contract Research Organizations in Ghana
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Panama
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Ukraine
- CRO list by country